Menopause (Support and Services) Bill

Judith Cummins Excerpts

2nd reading
Friday 29th October 2021 Commons Chamber

[Judith Cummins (Bradford South) (Lab)]

It is an honour to speak in the debate. I rise to support the Bill in the name of my hon. Friend the Member for Swansea East (Carolyn Harris), which I proudly put my name to. She has led the campaign on the Bill with her well-known enthusiasm, commitment and integrity. I am sure the whole House will join me in commending her on her approach.

[Hon. Members]

Hear, hear!

[Judith Cummins]

I will speak on one aspect of HRT and menopause: the link with osteoporosis. I do so as the co-chair of the all-party parliamentary group on osteoporosis and bone health. As I have said before, menopause is an important time for bone health. According to the Royal Osteoporosis Society, the decrease in oestrogen levels causes loss of bone density, so the menopause is an important cause of osteoporosis. Everyone loses bone density and strength as they get older, but women lose bone density more rapidly in the years following menopause. With that loss of bone density comes reduced bone strength and a greater risk of breaking bones. One of the many reasons that I support my hon. Friend’s Bill is that it is essential that women are properly supported around the time of menopause not just to assess their risk of osteoporosis and fractures but to be given appropriate advice and medication, including hormone replacement treatment, which reduces bone loss and the risk of fractures.

HRT is available only on prescription, and currently those accessing it are charged every time. That must change. The Bill’s provisions would be incredibly effective for the majority of women who take HRT. A recent survey of 1,000 women by Newson Health found: just one in five do not receive HRT as a repeat prescription; 86% receive a prescription for three months or less at a time; and 20% spend more than £150 on their NHS HRT prescriptions each year. The Bill’s provisions would create a useful cost saving for so many women accessing this important treatment.

Importantly, the Bill would also legislate for menopause for the first time and revolutionise how those who go through menopause are treated. Access to HRT must be widened to tackle misconceptions and ensure that those going through menopause can access the hormones to protect their bones and ease their experiences. Better education is needed in schools and for healthcare professionals to ensure that menopause symptoms are easily recognised and not misdiagnosed, as my hon. Friend and many others have said.

I am proud not just to help break the silence on the silent disease of osteoporosis but to break the taboo on talking about menopause, which is shrouded in mystery for many despite affecting over half the population at some point in their life. I support this Bill, which would undoubtedly help so many women to keep their bones safe and well.